Abstract
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for end-stage heart failure is a powerful tool to reverse acute shock and bridge a patient either to recovery, durable ventricular assist device (VAD), transplantation, or to extend a time for ongoing reevaluation of a patient’s clinical status. Patient selection is paramount. Patients without a reasonable chance for recovery or who are otherwise not candidates for advanced surgical therapy can have VA-ECMO initiation as a bridge to nowhere without an exit strategy. In this chapter, careful consideration is given to patients with heart failure requiring VA-ECMO in terms of patient selection, indications, management and auxiliary mechanical circulatory support (MCS) devices while on VA-ECMO.
Original language | English (US) |
---|---|
Title of host publication | Cardiopulmonary Bypass |
Subtitle of host publication | Advances in Extracorporeal Life Support |
Publisher | Elsevier |
Pages | 1243-1252 |
Number of pages | 10 |
ISBN (Electronic) | 9780443189180 |
DOIs | |
State | Published - Jan 1 2022 |
Keywords
- ECMO
- ELSO
- Ecpella
- Extracorporeal Life Support Organization
- Heart failure
- Heartmate
- Heartware
- Protek Duo
- TandemHeart
- extracorporeal membrane oxygenation
- impella
- mechanical circulatory support
ASJC Scopus subject areas
- General Agricultural and Biological Sciences
- General Biochemistry, Genetics and Molecular Biology